Taamil, Ana Jean R.

HRN: 28-71-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/23/2026
03/28/2026
PO
4ml
Q 6 Hours
Oropharyngeal Candidiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: